Metraipolis › archive › dc_eef3016f249d

Efficacy and safety of anlotinib for the treatment of advanced bone and soft tissue sarcomas: a systematic review and meta-analysis — Europe PMC PMID:41395622

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41395622
DOI
10.3389/fonc.2025.1703261
License (as archived)
solo-consultazione
Archived
2026-11-08T04:10:57.033Z
SHA-256 of the archived text
3e9e46d7d3cbd3dab89bde857a4485d09efd07fdc581d715c757f13c1cd5d5bf
Stable URL of this page
https://metraipolis.com/documento/dc_eef3016f249d

How to cite

Efficacy and safety of anlotinib for the treatment of advanced bone and soft tissue sarcomas: a systematic review and meta-analysis — Europe PMC PMID:41395622 — Europe PMC (en), https://europepmc.org/article/MED/41395622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eef3016f249d (Metraipolis archive dc_eef3016f249d, sha256 3e9e46d7d3cbd3dab89bde857a4485d09efd07fdc581d715c757f13c1cd5d5bf)
BibTeX
@misc{dceef3016f249d,
  title = {Efficacy and safety of anlotinib for the treatment of advanced bone and soft tissue sarcomas: a systematic review and meta-analysis — Europe PMC PMID:41395622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41395622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eef3016f249d; sha256 3e9e46d7d3cbd3dab89bde857a4485d09efd07fdc581d715c757f13c1cd5d5bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41395622. Agents can read the archived copy with the MCP tool read_document.